Luke Sergott
Stock Analyst at Barclays
(2.28)
# 2,964
Out of 4,407 analysts
709
Total ratings
42.6%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Upgraded: Buy | $310 → $400 | $328.82 | +21.65% | 10 | Jun 9, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $220 | $187.51 | +17.33% | 19 | Jun 8, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $625 | $469.34 | +33.17% | 44 | Jun 8, 2026 | |
| ICLR ICON Public Limited Company | Rated: Hold | $120 → $150 | $146.18 | +2.61% | 40 | May 29, 2026 | |
| A Agilent Technologies | Maintained: Buy | $140 → $145 | $129.84 | +11.68% | 32 | May 28, 2026 | |
| GH Guardant Health | Maintained: Buy | $120 | $131.62 | -8.83% | 17 | May 28, 2026 | |
| TWST Twist Bioscience | Maintained: Buy | $65 | $76.17 | -14.66% | 39 | May 26, 2026 | |
| CERT Certara | Rated: Hold | $8 → $6.5 | $5.20 | +25.00% | 35 | May 12, 2026 | |
| PACB Pacific Biosciences of California | Rated: Sell | $1 → $1.5 | $1.31 | +14.50% | 26 | May 11, 2026 | |
| MTD Mettler-Toledo International | Maintained: Buy | $1,500 | $1,131.49 | +32.57% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $280 | $212.07 | +32.03% | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $28.84 | +4.02% | 33 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $53 | $54.23 | -2.27% | 17 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $95 → $105 | $99.66 | +5.36% | 32 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $37.06 | +2.54% | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $425 | $355.53 | +19.54% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $160 | $130.59 | +22.52% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $181.46 | +15.73% | 47 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $16.19 | +11.18% | 41 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $16 | $16.48 | -2.91% | 19 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $110 → $122 | $160.97 | -24.21% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $290 | $266.16 | +8.96% | 15 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $9.39 | -25.45% | 43 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $500 → $450 | $467.34 | -3.71% | 9 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $230 | $180.10 | +27.71% | 44 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $230 | $203.06 | +13.27% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $42 | $8.49 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $289.36 | n/a | 1 | Jan 18, 2023 |
West Pharmaceutical Services
Jun 9, 2026
Upgraded: Buy
Price Target: $310 → $400
Current: $328.82
Upside: +21.65%
Charles River Laboratories International
Jun 8, 2026
Maintained: Buy
Price Target: $220
Current: $187.51
Upside: +17.33%
Thermo Fisher Scientific
Jun 8, 2026
Maintained: Buy
Price Target: $625
Current: $469.34
Upside: +33.17%
ICON Public Limited Company
May 29, 2026
Rated: Hold
Price Target: $120 → $150
Current: $146.18
Upside: +2.61%
Agilent Technologies
May 28, 2026
Maintained: Buy
Price Target: $140 → $145
Current: $129.84
Upside: +11.68%
Guardant Health
May 28, 2026
Maintained: Buy
Price Target: $120
Current: $131.62
Upside: -8.83%
Twist Bioscience
May 26, 2026
Maintained: Buy
Price Target: $65
Current: $76.17
Upside: -14.66%
Certara
May 12, 2026
Rated: Hold
Price Target: $8 → $6.5
Current: $5.20
Upside: +25.00%
Pacific Biosciences of California
May 11, 2026
Rated: Sell
Price Target: $1 → $1.5
Current: $1.31
Upside: +14.50%
Mettler-Toledo International
May 8, 2026
Maintained: Buy
Price Target: $1,500
Current: $1,131.49
Upside: +32.57%
May 8, 2026
Rated: Buy
Price Target: $280
Current: $212.07
Upside: +32.03%
May 8, 2026
Rated: Buy
Price Target: $30
Current: $28.84
Upside: +4.02%
May 7, 2026
Rated: Buy
Price Target: $45 → $53
Current: $54.23
Upside: -2.27%
May 7, 2026
Rated: Hold
Price Target: $95 → $105
Current: $99.66
Upside: +5.36%
May 7, 2026
Maintained: Hold
Price Target: $38
Current: $37.06
Upside: +2.54%
May 7, 2026
Maintained: Buy
Price Target: $400 → $425
Current: $355.53
Upside: +19.54%
May 6, 2026
Maintained: Buy
Price Target: $145 → $160
Current: $130.59
Upside: +22.52%
May 6, 2026
Maintained: Buy
Price Target: $210
Current: $181.46
Upside: +15.73%
May 6, 2026
Maintained: Buy
Price Target: $18
Current: $16.19
Upside: +11.18%
May 6, 2026
Maintained: Hold
Price Target: $11 → $16
Current: $16.48
Upside: -2.91%
May 1, 2026
Rated: Sell
Price Target: $110 → $122
Current: $160.97
Upside: -24.21%
May 1, 2026
Rated: Hold
Price Target: $290
Current: $266.16
Upside: +8.96%
Apr 30, 2026
Maintained: Sell
Price Target: $7
Current: $9.39
Upside: -25.45%
Apr 24, 2026
Maintained: Hold
Price Target: $500 → $450
Current: $467.34
Upside: -3.71%
Apr 22, 2026
Rated: Buy
Price Target: $230
Current: $180.10
Upside: +27.71%
Apr 22, 2026
Maintained: Buy
Price Target: $225 → $230
Current: $203.06
Upside: +13.27%
Jun 12, 2023
Maintained: Hold
Price Target: $35 → $42
Current: $8.49
Upside: n/a
Jan 18, 2023
Rated: Buy
Price Target: $200
Current: $289.36
Upside: n/a